Davila ML - Search Results

1

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies.

Jain MD, Davila ML. Jain MD, et al. Among authors: davila ml. Stem Cells. 2018 Jan;36(1):36-44. doi: 10.1002/stem.2715. Epub 2017 Oct 25. Stem Cells. 2018. PMID: 29024301 Review.

2

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies.

Davila ML, Bouhassira DC, Park JH, Curran KJ, Smith EL, Pegram HJ, Brentjens R. Davila ML, et al. Int J Hematol. 2014 Apr;99(4):361-71. doi: 10.1007/s12185-013-1479-5. Epub 2013 Dec 6. Int J Hematol. 2014. PMID: 24311149 Free PMC article. Review.

3

Biology and clinical application of CAR T cells for B cell malignancies.

Davila ML, Sadelain M. Davila ML, et al. Int J Hematol. 2016 Jul;104(1):6-17. doi: 10.1007/s12185-016-2039-6. Epub 2016 Jun 4. Int J Hematol. 2016. PMID: 27262700 Free PMC article. Review.

4

At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies.

Oluwole OO, Davila ML. Oluwole OO, et al. Among authors: davila ml. J Leukoc Biol. 2016 Dec;100(6):1265-1272. doi: 10.1189/jlb.5BT1115-524R. Epub 2016 Jun 27. J Leukoc Biol. 2016. PMID: 27354412 Review.

5

Gammaretroviral Production and T Cell Transduction to Genetically Retarget Primary T Cells Against Cancer.

Li G, Park K, Davila ML. Li G, et al. Among authors: davila ml. Methods Mol Biol. 2017;1514:111-118. doi: 10.1007/978-1-4939-6548-9_9. Methods Mol Biol. 2017. PMID: 27787796

6

CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Davila ML, Brentjens RJ. Davila ML, et al. Clin Adv Hematol Oncol. 2016 Oct;14(10):802-808. Clin Adv Hematol Oncol. 2016. PMID: 27930631 Free PMC article. Review.

7

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.

Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, Sauter C, Wang Y, Santomasso B, Mead E, Roshal M, Maslak P, Davila M, Brentjens RJ, Sadelain M. Park JH, et al. N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919. N Engl J Med. 2018. PMID: 29385376 Free PMC article. Clinical Trial.

8

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.

Sallman DA, Brayer J, Sagatys EM, Lonez C, Breman E, Agaugué S, Verma B, Gilham DE, Lehmann FF, Davila ML. Sallman DA, et al. Among authors: davila ml. Haematologica. 2018 Sep;103(9):e424-e426. doi: 10.3324/haematol.2017.186742. Epub 2018 Apr 27. Haematologica. 2018. PMID: 29703727 Free PMC article. No abstract available.

9

CAR T cells, immunologic and cellular therapies in hematologic malignancies.

Brentjens R, Davila ML. Brentjens R, et al. Among authors: davila ml. Best Pract Res Clin Haematol. 2018 Jun;31(2):115-116. doi: 10.1016/j.beha.2018.05.001. Epub 2018 May 18. Best Pract Res Clin Haematol. 2018. PMID: 29909911 Free PMC article. No abstract available.

10

4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

Li G, Boucher JC, Kotani H, Park K, Zhang Y, Shrestha B, Wang X, Guan L, Beatty N, Abate-Daga D, Davila ML. Li G, et al. Among authors: davila ml. JCI Insight. 2018 Sep 20;3(18):e121322. doi: 10.1172/jci.insight.121322. eCollection 2018 Sep 20. JCI Insight. 2018. PMID: 30232281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters